Poll: What Is Your Prediction for 2021?

Article

The year 2021 could bring momentous developments in the biosimilar field.

Which do you think is most likely to occur in 2021?

The Supreme Court strikes down the whole Affordable Care Act and its biosimilar approval pathway.
The FDA approves the first insulin biosimilar.
Innovator companies launch lower-cost "authorized biologics" in response to biosimilar competition.
The FDA approves the first interchangeable biosimilar.

See what our Advisory Board had to say about 2020 and 2021 in biosimilars.

Related Videos
Here are the top 5 biosimilar articles for the week of September 18, 2023.
Here are the top 5 biosimilar articles for the week of September 11, 2023.
Fran Gregory, PharmD, MBA
Here are the top 5 biosimilar articles for the week of August 28, 2023.
Here are the top 5 biosimilar articles for the week of August 28, 2023.
Fran Gregory, PharmD, MBA
Here are the top 5 biosimilar articles for the week of August 21, 2023.
Here are the top 5 biosimilar articles for the week of August 14, 2023.
Related Content
© 2023 MJH Life Sciences

All rights reserved.